TIGR®Matrix shows promising results when used for incisional hernia prevention in septic patients undergoing laparoscopy

By: News Feed | Last updated: 4th December 2018 | In: Medical News Asia, Oncology, Surgery

Article Keywords

hernia, NovusScientific, resorbable mesh, surgical matrix, surgical mesh, synthetic mesh, TIGR

UPPSALA, Sweden, Dec. 4, 2018 /PRNewswire/ — Onlay mesh placement of the synthetic and fully resorbable TIGR^®Matrix surgical mesh (Novus Scientific AB, Uppsala — Sweden) for the prevention of incisional hernia in septic patients undergoing emergency laparoscopy showed encouraging efficacy and safety in a small retrospective study, as presented during the XXVIII Waterford Surgical October Club Meeting.

Approximately one in three patients undergoing emergency laparotomy develop an incisional hernia. A recent, major paradigm shift in abdominal closure is onlay surgical mesh insertion as a prophylactic measure to prevent incisional hernia at the initial operation or completion of a temporary abdominal closure. However, conceptual difficulties complicate such procedure in patients with sepsis.

Lead author Michael Moore and colleagues presented a small retrospective case series in six septic patients undergoing onlay mesh placement with TIGR^®Matrix surgical mesh post-emergency laparotomy at a single institution.

The TIGR^®Matrix resulted in a low complication rate. No post-procedural incisional hernias were reported, and no patients developed a seroma. One patient was reported to have a wound infection.

Onlay TIGR^®Matrix surgical mesh placement in septic patients undergoing emergency laparoscopy is encouraging, concluded the investigators of the Letterkenny University Hospital. A long-term follow-up is required to validate these results.

About the TIGR^®Matrix

TIGR^®Matrix is the first long-term resorbable, 100% synthetic, surgical mesh. Its unique technology consisting of dual-stage degradation and full resorption, paired with ease of use, is a significant step forward in surgical mesh technology.

The fast-degrading part improves the meshes’ flexibility and stretchability, provides extra strength during the immediate healing phase, and gradually absorbs during the first four months. The slow-degrading part of the mesh provides optimal strength for up to nine months with complete resorption in approximately three years. TIGR^®Matrix uses 100% synthetic polymers that are well documented, clinically proven, and commonly used in medical devices since the 1970s.

About the Novus Scientific

Novus Scientific AB (www.novusscientific.com) develops, manufactures and markets resorbable implants that help the body’s own healing.

The headquarter, research and production facilities are located in Uppsala, Sweden.

Source

Moore M, et al. Prevention of incisional hernia post emergency laparotomy:
A time to change? A case series. Presented at the XXVIII Waterford Surgical October Club Meeting, 13 October 2018.

Newsletter Sign-Up

Do you like our content? Subscribe to our non-intrusive newsletter today! We promise we won’t be spammy.

Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?

Erasmus University MC investigating a new surgical matrix to reduce post-operative complications

Fully resorbable synthetic matrix offers improved safety for breast cancer patients undergoing immediate breast reconstruction

Anti-PD1 sintilimab plus biosimilar bevacizumab receive IND-status by China NMPA

26th April 2019

Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?

16th January 2019

Erasmus University MC investigating a new surgical matrix to reduce post-operative complications

Disclaimer

This article is not medical advice. Patients should seek personal assessment by a licenced specialist. Physicians are recommended to read the full publication(s) as cited in the article before making medical decisions. This article does not supersede nor replace the published article(s).